Efficacy and safety of onabotulinumtoxinA for treatment of pediatric upper limb spasticity: Primary results
Sign Up to like & getrecommendations! Published in 2018 at "Toxicon"
DOI: 10.1016/j.toxicon.2018.11.080
Abstract: the authors by Karen Pemberton, PhD, of Evidence Scientifi c Solutions, Inc, and funded by Allergan plc. All authors met the ICMJE authorship criteria. Neither honoraria nor payments were made for authorship. Financial arrangements of… read more here.
Keywords: efficacy safety; allergan plc; treatment pediatric; neurotoxin association ... See more keywords
OnabotulinumtoxinA for Treatment of Forehead and Glabellar Lines: Subject-Reported Satisfaction and Impact From a Phase 3 Double-Blind Study
Sign Up to like & getrecommendations! Published in 2019 at "Dermatologic Surgery"
DOI: 10.1097/dss.0000000000001779
Abstract: BACKGROUND Patient-reported outcomes are important measures of treatment benefit in facial aesthetic medicine. OBJECTIVE Evaluate prespecified subject-reported satisfaction and impact outcomes with onabotulinumtoxinA treatment of forehead lines (FHL) and glabellar lines (GL). METHODS The study… read more here.
Keywords: onabotulinumtoxina treatment; treatment; impact; satisfaction ... See more keywords
Safety, Efficacy, and Patient Satisfaction With OnabotulinumtoxinA for the Treatment of Upper Facial Lines in Japanese Subjects.
Sign Up to like & getrecommendations! Published in 2019 at "Dermatologic Surgery"
DOI: 10.1097/dss.0000000000002143
Abstract: BACKGROUND OnabotulinumtoxinA treatment for glabellar lines (GL) or crow's-feet lines (CFL) was previously studied in Japanese subjects. OBJECTIVE To assess safety and efficacy of repeated onabotulinumtoxinA for moderate to severe GL and CFL in Japanese… read more here.
Keywords: treatment; japanese subjects; onabotulinumtoxina treatment; safety efficacy ... See more keywords
OnabotulinumtoxinA for the treatment of major depressive disorder: a phase 2 randomized, double-blind, placebo-controlled trial in adult females
Sign Up to like & getrecommendations! Published in 2019 at "International Clinical Psychopharmacology"
DOI: 10.1097/yic.0000000000000290
Abstract: Supplemental Digital Content is available in the text. read more here.
Keywords: depressive disorder; major depressive; onabotulinumtoxina treatment; phase randomized ... See more keywords
OnabotulinumtoxinA for the treatment of headache: an updated review.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of integrative neuroscience"
DOI: 10.31083/j.jin2101037
Abstract: Botulinum toxin (BT) is a neurotoxin produced by Clostridium botulinum, a gram-positive anaerobic bacterium. Systemic human intoxication from BT following oral ingestion results in acute and life-threatening muscle paralysis called botulism. BT has a wide… read more here.
Keywords: treatment headache; updated review; onabotulinumtoxina treatment; headache updated ... See more keywords